https://www.selleckchem.com/pr....oducts/Mizoribine.ht
contrast MRI can be used for HCC surveillance is warranted. There has been increased interest in interventions to promote hepatocellular carcinoma (HCC) surveillance given low utilization and high proportions of late stage detection. Accurate prediction of patients likely versus unlikely to respond to interventions could allow a cost-effective approach to outreach and facilitate targeting more intensive interventions to likely non-responders. We conducted a secondary analysis of a randomized clinical trial evaluating a mailed outreac
Like
Comment
Share
